Distribution of p63, a novel myoepithelial marker, in fine-needle aspiration biopsies of the breast: An analysis of 82 samples

Cancer

Volumn 99, Issue 3, 2003, Pages 172-179

  Reis Filho, Jorge S ^a,b   Milanezi, Fernanda ^a   Amendoeira, Isabel ^c   Albergaria, André ^a   Schmitt, Fernando C ^a,c  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF MINHO   (Portugal)

^c University of Porto   (Portugal)

Author keywords

Breast; Fine needle aspiration; Immunocytochemistry; Myoepithelial cells; Myoepithelium; Naked nuclei; p63

Indexed keywords

BIOTIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 4A4; PEROXIDASE; PROTEIN P63; STREPTAVIDIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; BASAL CELL; BREAST BIOPSY; BREAST CARCINOMA; BREAST TUMOR; CANCER CELL; CELL NUCLEUS; CELL STRUCTURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FIBROADENOMA; GENE LOCATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MYOEPITHELIUM CELL; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; VALIDATION PROCESS;

ADULT; AGED; BIOLOGICAL MARKERS; BIOPSY, NEEDLE; BREAST NEOPLASMS; DNA-BINDING PROTEINS; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MYOEPITHELIOMA; PHOSPHOPROTEINS; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEINS;

EID: 0038458958     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11061     Document Type: Article

References (34)

1. McKee GT, Tambouret RH, Finkelstein D. Fine-needle aspiration cytology of the breast: invasive vs. in situ carcinoma. Diagn Cytopathol. 2001;25:73-77.
2. Bondeson L, Lindholm K. Prediction of invasiveness by aspiration cytology applied to nonpalpable breast carcinoma and tested in 300 cases. Diagn Cytopathol. 1997;17:315-320.
3. Denley H, Pinder SE, Elston CW, et al. Preoperative assessment of prognostic factors in breast cancer. J Clin Pathol. 2001;54:20-24.
4. Dabbs DJ, Gown AM. Distribution of calponin and smooth muscle myosin heavy chain in fine-needle aspiration biopsies of the breast. Diagn Cytopathol. 1999;20:203-207.
5. Yaziji H, Gown AM, Sneige N. Detection of stromal invasion in breast cancer: the myoepithelial markers. Adv Anat Pathol. 2000;7:100-109.
6. Foschini MP, Scarpellini F, Gown AM, Eusebi V. Differential expression of myoepithelial markers in salivary, sweat and mammary glands. Int J Surg Pathol. 2000;8:29-37.
7. Reis-Filho JS, Milanezi F, Silva P, Schmitt FC. Maspin expression in myoepithelial tumors of the breast. Pathol Res Pract. 2001;197:817-821.
8. Ohyabu I, Takasaki T, Akiba S, et al. Immunohistochemical studies on expression of human vascular smooth muscle myosin heavy chain isoforms in normal mammary glands, benign mammary disorders and mammary carcinomas. Pathol Int. 1998;48:433-439.
9. Mosunjac MB, Lewis MM, Lawson D, Cohen C. Use of a novel marker, calponin, for myoepithelial cells in fine-needle aspirates of papillary breast lesions. Diagn Cytopathol. 2000;23:151-155.
10. Lazard D, Sastre X, Frid MG, Glukhova MA, Thiery JP, Koteliansky VE. Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue. Proc Natl Acad Sci USA. 1993;90:999-1003.
11. Nayar R, Breland C, Bedrossian U, Masood S, DeFrias D, Bedrossian CW. Immunoreactivity of ductal cells with putative myoepithelial markers: a potential pitfall in breast carcinoma. Ann Diagn Pathol. 1999;3:165-173.
12. Masood S, Lu L, Assaf-Munasifi M, McCaulley K. Application of immunostaining for muscle specific actin in detection of myoepithelial cells in breast fine-needle aspirates. Diagn Cytopathol. 1995;13:71-74.
13. Barbareschi M, Pecciarini L, Cangi MG, et al. p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast. Am J Surg Pathol. 2001;25:1054-1060.
14. Reis Filho JS, Schmitt FC. Taking advantage of basic research: p63 is a reliable myoepithelial and stem cell marker. Adv Anat Pathol. 2002;9:280-289.
15. Schmitt FC, Bento MJ, Amendoeira I. Estimation of estrogen receptor content in fine-needle aspirates from breast cancer using the monoclonal antibody ID5 and microwave oven processing: correlation with paraffin embedded and frozen sections determinations. Diagn Cytopathol. 1995;13:347-351.
16. Reis Filho JS, Torio B, Albergaria A, Schmitt FC. P63 expression in normal skin and usual cutaneous carcinomas. J Cutan Pathol. 2002;29:517-523.
17. Moinfar F, Man YG, Lininger RA, Bodian C, Tavassoli FA. Use of keratin 35betaE12 as an adjunct in the diagnosis of mammary intraepithelial neoplasia-ductal type - benign and malignant intraductal proliferations. Am J Surg Pathol. 1999;23:1048-1058.
18. Raju U, Crissman JD, Zarbo RJ, Gottlieb C. Epitheliosis of the breast. An immunohistochemical characterization and comparison to malignant intraductal proliferations of the breast. Am J Surg Pathol. 1990;14:939-947.
19. Otterbach F, Bankfalvi A, Bergner S, Decker T, Krech R, Boecker W. Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis of atypical proliferations of the breast. Histopathology. 2000;37:232-240.
20. Chu PG, Weiss LM. Cytokeratin 14 immunoreactivity distinguishes oncocytic tumour from its renal mimics: an immunohistochemical study of 63 cases. Histopathology. 2001;39:455-462.
21. Lakhani SR, O'Hare MJ. The mammary myoepithelial cell Cinderella or ugly sister? Breast Cancer Res. 2001;3:1-4.
22. Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, Bradley A. p63 Is a p53 homologue required for limb and epidermal morphogenesis. Nature. 1999;398:708-713.
23. Yang A, Schweitzer R, Sun D, et al. p63 Is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature. 1999;398:714-718.
24. Levrero M, De Laurenzi V, Costanzo A, Gong J, Wang JY, Melino G. The p53/p63/p73 family of transcription factors: overlapping and distinct functions. J Cell Sci. 2000;113:1661-1670.
25. Di Como CJ, Urist MJ, Babayan I, et al. p63 Expression profiles in human normal and tumor tissues. Clin Cancer Res. 2002;8:494-501.
26. Kaufmann O, Fietze E, Mengs J, Dietel M. Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas. Am J Clin Pathol. 2001;116:823-830.
27. Marasa L, Tomasino RM. Aspiration cytology of the breast. II. Significance of bipolar naked nuclei. Pathologica. 1982; 74:193-200.
28. Tsuchiya S, Maruyama Y, Koike Y, Yamada K, Kobayashi Y, Kagaya A. Cytologic characteristics and origin of naked nuclei in breast aspirate smears. Acta Cytol. 1987;31:285-290.
29. Zajicek J, Caspersson T, Jakobsson P, Kudinowski J, Linsk J, Us-Krasovec M. Cytological diagnosis of mammary tumors from aspiration biopsy smears: comparison of cytological and histological findings in 2111 lesions and diagnostic use of cytophotometry. Acta Cytol. 1970;14:370-376.
30. Ferguson DJ, Wells CA, Crucioli V. Ultrastructural analysis of fine needle aspirates from benign breast lesions. J Clin Pathol. 1990;43:22-26.
31. Reis-Filho JS, Milanezi F, Paredes J, Pereira EM, Schmitt FC. Maspin, p63 and p-cadherin expression in metaplastic breast carcinomas: new insights into a putative myoepithelial histogenesis/differentiation [abstract]. Mod Pathol. 2002;15:191.
32. Wang X, Mori I, Tang W, et al. Metaplastic carcinoma of the breast: p53 analysis identified the same point mutation in the three histologic components. Mod Pathol. 2001;14:1183-1186.
33. Jones C, Nonni AV, Fulford L, et al. CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation. Br J Cancer. 2001;85:422-427.
34. Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature. 2000;406:747-752.